Skip to content

Vor Biopharma VOR Prepaid & Other Current

Prepaid & Other Current at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$4.82B+17.8%
Amgen logo
AmgenAMGN
$4.11B+26.2%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$720.8M+12.1%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$7.42M+9.6%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$4.23M+6.4%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$9.52M-31.7%

Other financials

Income statement

See full
Operating income-$35.2M-5.6%
Net income-$219.6M-576%
EPS (diluted)-$5.11+1.9%

Balance sheet

See full
Cash & equivalents$169.9M+239%
Total debt$2.9M-90.5%
Total equity-$150.4M-328%
Total assets$506.7M+364%

Cash flow

See full
Operating cash flow-$38.2M-23.1%
CapEx$48.0K-79.2%
Free cash flow-$38.3M-22.4%

Valuation

See full
Market cap$784.61M+2,594%
Enterprise value$617.68M+5,866%

Returns & leverage

See full
Return on equity-125.4%+671pp
Debt / equity0.5×+0.2×
Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vor Biopharma's prepaid & other current?
Vor Biopharma (VOR) reported prepaid & other current of $6.39M in Q1 2026.
How has Vor Biopharma's prepaid & other current changed year-over-year?
Vor Biopharma's prepaid & other current increased by 41.6% year-over-year, from $4.52M to $6.39M.
What is the long-term trend for Vor Biopharma's prepaid & other current?
Over 4 years (2021 to 2025), Vor Biopharma's prepaid & other current has grown at a -19.0% compound annual growth rate (CAGR), from $18.36M to $7.91M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.